RecruitingNCT07087418

AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases

Sponsor: First Affiliated Hospital, Sun Yat-Sen University

Trial Details

Condition	Digestive Diseases, Radiology, AI (Artificial Intelligence), Imaging
Intervention	Virtual endoscopy model-assisted diagnosis
Status	Recruiting
Participants	5,000
Est. Completion	1 Aug 2026
Last Updated	13 Apr 2026

Primary Outcome

The area under the ROC curve (AUC) to assess the performance of diagnostic model.

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patients with multimodal-confirmed diagnoses (clinical, imaging, endoscopic, and pathological) of: * Inflammatory bowel disease (IBD; Crohn's disease or ulcerative colitis) * Intestinal tuberculosis * Behçet's disease * Availability of ≥1 technically adequate CT or MR scan with high-quality colonoscopy performed within ±1 month of imaging. Exclusion Criteria: * ・Suboptimal imaging quality (e.g., low-dose artifacts, metal artifacts) * Inadequate bowel preparation for endoscopy * Incomplete examinations due to poor tolerance

Trial Sites

Countries

China

View Registry Entry

Related Analysis

Landmark AI-Imaging Study Targets Non-Invasive Diagnosis of IBD and Intestinal TB — 5,000-Patient Trial Opens

A landmark 5,000-patient study is developing AI-enhanced imaging to non-invasively diagnose IBD, intestinal tuberculosis, and Behçet's disease. This could revolutionise gastroenterology by reducing reliance on invasive endoscopic procedures.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service